Endo Daily Endo Daily
  • Home
  • Daily News
    • Archive
      • 2017
      • 2016
      • 2015
  • Meeting Home
Menu
  • Home
  • Daily News
    • Archive
      • 2017
      • 2016
      • 2015
  • Meeting Home
loading...
Home News ENDO 2019 Announces Plenary Speaker Lineup

ENDO 2019 Announces Plenary Speaker Lineup

on: February 04, 2019
Print Email

ENDO 2019 will feature a plenary program of prominent speakers and cutting edge topics during the March 23-26 event at the Ernest N. Morial Convention center in New Orleans, La.

This year’s presidential plenary address on March 23 will be given by Francis S. Collins, MD, PhD, Director of the National Institutes of Health (NIH) on “Whole Genome Approaches to Unraveling Diseases.”

Dr. Collins is a renowned speaker and talented physician-geneticist noted for his landmark discoveries of disease genes. He’s well known for his leadership of the international Human Genome Project, and he previously served as the director of the NIH’s National Human Genome Research Institute. He will kick off ENDO 2019 with a presidential plenary on translating whole genome data to disease.

Other noteworthy speakers are Robert Califf, MD, Duke University School of Medicine and former Food & Drug Administration (FDA) Commissioner, and Cori Bargmann, PhD, Rockefeller University and head of the Chan Zuckerberg Initiative’s science work. Dr. Califf and Dr. Bargmann will address “Utilizing Big Data in Science and Clinical Care” on March 25.

Other plenary talks scheduled during the event Include:

  • Gene Editing and Stem Cells: Using Reproductive Technology for Early Disease Treatment (March 23)
    Juan Carlos Izpisua Belmonte, Ph.D., Salk Institute, La Jolla, Calif.
    Marisa Bartolomei, Ph.D., University of Pennsylvania, Philadelphia, Pa.
  • Novel Therapeutic Targets in Metabolic Disease and Cancer (March 24)
    Myles Brown, M.D., Dana-Farber Cancer Institute, Boston, Mass.
    Peter J. Tontonoz, M.D., Ph.D., University of California-Los Angeles, Los Angeles, Calif.
  • Hormone Science to Health: The Endocrine Society Goes to the National Academy of Sciences (March 24)
    Barbara B. Kahn, M.S., M.D., Beth Israel Deaconess Medical Center, Boston, Mass.
    Christopher Glass, M.D., Ph.D., University of California – San Diego, La Jolla, Calif.
    Mitchell A. Lazar, M.D., Ph.D., University of Pennsylvania
  • Targeting Senescent Cells in Aging and Disease (March 25)
    Jan M. van Deursen, Ph.D., Mayo Clinic, Rochester, Minn. Sundeep Khosla, M.D., Mayo Clinic College of Medicine

For recaps and highlights of these plenaries, check back here at endodaily.org during the meeting.

Share 0
Tweet
Share 0
  • ENDO 2019 Announces Plenary Speaker Lineup
    Previous

    Society Must Partner with Our Members, Sister Societies to Advance the Specialty

  • Next

    Endocrine Society honors endocrinology field’s leaders with 2019 Laureate Awards

Follow ENDO on Twitter

Tweets by @theendosociety

Follow ENDO on Instagram

Endocrine Society

© 2019 Endocrine Society, All Rights Reserved. Powered By TriStar Publishing, Inc. | Privacy Policy